서브이미지

COMPANY

HealthBiome is going to contribute to the promotion of human
health through continuous research and development
HealthBiome is going to contribute
to the promotion of human health through
continuous research and development

History
2026
Market launch of HB05P with Samyang Foods in the Korean market - "Akkermansia for Strength" (brand: Spindle)
2025
MFDS approval for HB05P as a functional ingredient for muscle strength
FDA NDI acknowledgment for HB05P (higher dose)
Completed the high-dose clinical trial of HB05P for muscle strength
Jeonju plant earns GMP and HACCP certification
Jeonju plant receives MFDS health-functional-food GMP certification
2024
FDA NDI acknowledgment for HB05P (lower dose)
Partnership with Samyang Foods for HB05P in the Korean health-functional-food market
Manufacturing plant established in Jeonju
Completed the low-dose clinical trial of HB05P for muscle strength
2022
Closed Series B financing
Secured self-affirmed GRAS status for HB05P
Completed GLP toxicology studies for HB05P
2020
Closed Series A financing
Funding from the KIBO
2017–19
Certified corporate R&D institute (2019)
Certified as a venture company · seed and angel funding (2018)
HealthBiome founded (2017)